Zidovudine |
Myelosuppression |
This calls for reduction in valganciclovir dosage or substitution with a different antiretroviral drug. |
Didanosine |
Paradoxical decline in the CD4 cell counts, despite persistent suppression of viral load |
The probable explanation is the inhibition of purine nucleoside phosphorylase by ganciclovir and its prodrug valganciclovir. |
Mycophenolate mofetil22
|
Myelosuppression |
Granulocytopenia reversed with granulocyte-colony stimulating factor |
Probenecid22
|
Reduces renal clearance and increases plasma concentration |
Close monitoring advised |
Imipenem/cilastatin |
Induces convulsions |
No human studies done |
Stavudine/zalcitabine/trimethoprim22
|
No untoward effects reported |
|
Nephrotoxic drugs such as aminoglycosides, cisplatin, tacrolimus and amphotericin B12
|
Increased nephrotoxicity |
Avoidance or cautious administration is advised |